Universal Scientific Industrial (Shanghai) (601231) Q2 2025 earnings summary

Executive summary

• Revenue for January–June 2025 was RMB 27.21 billion, down 0.63% year-over-year from the same period in 2024.

• Net profit attributable to shareholders was RMB 638.05 million, a decrease of 18.66% year-over-year.

• Operating profit for the period was RMB 750.47 million, down from RMB 829.89 million in the prior year.

• Operating profit fell 9.57% and EBITDA declined 11.74% compared to the same period last year.

Financial highlights

• Total assets as of June 30, 2025, were RMB 39.78 billion, slightly down from RMB 39.99 billion at year-end 2024.

• Net assets attributable to shareholders increased 3.08% to RMB 18.49 billion.

• Basic and diluted EPS were both RMB 0.29, down 19.44% year-over-year.

• Cash conversion cycle improved by 5 days to 43 days.

• Net cash flows from operating activities were RMB 1.44 billion, a 3.63% decrease year-over-year.

Key financial ratios and metrics

• Weighted average return on equity was 3.48%, down 1.10 percentage points year-over-year.

• Return on total assets was 1.89%, down 0.61 percentage points year-over-year.

• Period expenses as a percentage of revenue rose to 7.56% from 7.16% last year.